Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 30;21(3):906.
doi: 10.3390/ijms21030906.

In Vitro Evaluation of Different Prebiotics on the Modulation of Gut Microbiota Composition and Function in Morbid Obese and Normal-Weight Subjects

Affiliations

In Vitro Evaluation of Different Prebiotics on the Modulation of Gut Microbiota Composition and Function in Morbid Obese and Normal-Weight Subjects

Alicja M Nogacka et al. Int J Mol Sci. .

Abstract

The gut microbiota remains relatively stable during adulthood; however, certain intrinsic and environmental factors can lead to microbiota dysbiosis. Its restoration towards a healthy condition using best-suited prebiotics requires previous development of in vitro models for evaluating their functionality. Herein, we carried out fecal cultures with microbiota from healthy normal-weight and morbid obese adults. Cultures were supplemented with different inulin-type fructans (1-kestose, Actilight, P95, Synergy1 and Inulin) and a galactooligosaccharide. Their impact on the gut microbiota was assessed by monitoring gas production and evaluating changes in the microbiota composition (qPCR and 16S rRNA gene profiling) and metabolic activity (gas chromatography). Additionally, the effect on the bifidobacterial species was assessed (ITS-sequencing). Moreover, the functionality of the microbiota before and after prebiotic-modulation was determined in an in vitro model of interaction with an intestinal cell line. In general, 1-kestose was the compound showing the largest effects. The modulation with prebiotics led to significant increases in the Bacteroides group and Faecalibacterium in obese subjects, whereas in normal-weight individuals, substantial rises in Bifidobacterium and Faecalibacterium were appreciated. Notably, the results obtained showed differences in the responses among the tested compounds but also among the studied human populations, indicating the need for developing population-specific products.

Keywords: HT29; RTCA; SCFA; bifidobacterial-ITS; functionality; gas production; in vitro model; microbiota; obesity; prebiotics.

PubMed Disclaimer

Conflict of interest statement

Takumi Tochio and Katsuaki Hirano are employees at the company β- Food Sciences.

Figures

Figure 1
Figure 1
Microbial composition (relative abundance %) evaluated by 16S rRNA gene profiling at family levels in basal conditions (time 0: T0) and after 24 h of incubation in fecal cultures with several carbon sources and without an external carbon source added (Control) in morbid obesity (MOB) and normal-weight (NW) groups.
Figure 2
Figure 2
Absolute levels (Log CFU/mL) of fecal microbial groups determined by qPCR after fecal cultures of (A) MOB and (B) NW subjects. For each microbial group, the box and whiskers plot represent median, interquartile range and minimum and maximum values obtained in each human group (NW or MOB). Different letters above the boxes indicate significant differences (p-value < 0.05) among carbon sources for the microbial groups considered.
Figure 3
Figure 3
Increments in ascending order, with respect to time 0, in the concentration (mM) of the major short-chain fatty acids (acetic, propionic and butyric) after 24 h of incubation with different carbon sources in fecal cultures from MOB (A) and NW (B) groups. Differences are shown for each short-chain fatty acid (SCFA); columns that do not share the same letter are significantly different (p < 0.05).
Figure 4
Figure 4
Real-time monitoring the interaction between (A) fecal supernatants and (B) isolated microbiota obtained before and after incubation with prebiotics and HT29 intestinal epithelial cells. Values (media ± SD) correspond to the Area Under the Curve (AUC) resulting from monitoring the cell index (CI) during 10 h. Significant differences (p-value < 0.05) represent the comparison of results before and after prebiotics addition in each condition.

Similar articles

Cited by

References

    1. Lloyd-Price J., Abu-Ali G., Huttenhower C. The healthy human microbiome. Genome Med. 2016;8:51. doi: 10.1186/s13073-016-0307-y. - DOI - PMC - PubMed
    1. Levy M., Kolodziejczyk A.A., Thaiss C.A., Elinav E. Dysbiosis and the immune system. Nat. Rev. Immunol. 2017;17:219–232. doi: 10.1038/nri.2017.7. - DOI - PubMed
    1. Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., Scott K., Stanton C., Swanson K.S., Cani P.D., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2017;14:491–502. doi: 10.1038/nrgastro.2017.75. - DOI - PubMed
    1. Vernazza C.L., Rabiu A.R., Gibson G.R. Human Colonic Microbiology and the Role of Dietary Intervention: Introduction to Prebiotics. In: Gibson G.R., Rastall R.A., editors. Prebiotics: Development & Application. John Wiley & Sons, Ltd.; Chichester, UK: 2006.
    1. DeVuyst L., Leroy F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int. J. Food Microbiol. 2011;149:73–80. doi: 10.1016/j.ijfoodmicro.2011.03.003. - DOI - PubMed

Publication types